These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11348693)

  • 41. Impact of varying panel membership on ratings of appropriateness in consensus panels: a comparison of a multi- and single disciplinary panel.
    Coulter I; Adams A; Shekelle P
    Health Serv Res; 1995 Oct; 30(4):577-91. PubMed ID: 7591782
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Practice patterns among primary care physicians in benign prostatic hyperplasia and prostate cancer.
    Fawzy A; Fontenot C; Guthrie R; Baudier MM
    Fam Med; 1997 May; 29(5):321-5. PubMed ID: 9165283
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Guide dedicated to general practitioner for the management of lower urinary tract symptoms related to benign prostatic hyperplasia].
    Descazeaud A; Barry Delongchamps N; Cornu JN; Azzouzi AR; Buchon D; Benchikh A; Coloby P; Dumonceau O; Fourmarier M; Haillot O; Lebdai S; Mathieu R; Misrai V; Saussine C; de La Taille A; Robert G;
    Prog Urol; 2015 Jun; 25(7):404-12. PubMed ID: 25841758
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Factors determining treatment strategies for patients with benign prostatic hyperplasia. The DUO study].
    Fourcade RO; Picot MC; Gaudin AF; Texier N; Slama A
    Presse Med; 2007 May; 36(5 Pt 1):755-63. PubMed ID: 17329070
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patterns in the diagnosis and management of benign prostatic hyperplasia in a country that does not have country-specific clinical practice guidelines.
    Paick JS; Kim SW; Ku JH
    Yonsei Med J; 2007 Apr; 48(2):281-8. PubMed ID: 17461528
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A population based study of incidence and treatment of benign prostatic hyperplasia among residents of Olmsted County, Minnesota: 1987 to 1997.
    Sarma AV; Jacobson DJ; McGree ME; Roberts RO; Lieber MM; Jacobsen SJ
    J Urol; 2005 Jun; 173(6):2048-53. PubMed ID: 15879823
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effectiveness of a treatment protocol for male lower urinary tract symptoms in general practice: a practical randomised controlled trial.
    Norg RJ; van de Beek K; Portegijs PJ; van Schayck CP; Knottnerus JA
    Br J Gen Pract; 2006 Dec; 56(533):938-44. PubMed ID: 17132382
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Appropriateness of colorectal cancer screening: appraisal of evidence by experts.
    Bridevaux IP; Silaghi AM; Vader JP; Froehlich F; Gonvers JJ; Burnand B
    Int J Qual Health Care; 2006 Jun; 18(3):177-82. PubMed ID: 16603584
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Economic analysis of finasteride: a model-based approach using data from the Proscar Long-Term Efficacy and Safety Study.
    Albertsen PC; Pellissier JM; Lowe FC; Girman CJ; Roehrborn CG
    Clin Ther; 1999 Jun; 21(6):1006-24. PubMed ID: 10440624
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [S2e guideline of the German urologists: Conservative and pharmacologic treatment of benign prostatic hyperplasia].
    Höfner K; Bach T; Berges R; Dreikorn K; Gratzke C; Madersbacher S; Michel MS; Muschter R; Oelke M; Reich O; Tschuschke C; Bschleipfer T
    Urologe A; 2016 Feb; 55(2):184-94. PubMed ID: 26518303
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of Characteristics of Benign Prostatic Hyperplasia (BPH) Patients Treated with Finasteride and Alpha Blocker Combination Therapy Versus Alpha Blocker Monotherapy in China: An Analysis of Electronic Medical Record Data.
    Fu Y; Han S; Wang L; Gao W; Wu E; Cao X; Wang J
    Adv Ther; 2018 Aug; 35(8):1191-1198. PubMed ID: 30014350
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evidence-based guidelines for the management of lower urinary tract symptoms related to uncomplicated benign prostatic hyperplasia in Italy: updated summary.
    Spatafora S; Conti G; Perachino M; Casarico A; Mazzi G; Pappagallo GL;
    Curr Med Res Opin; 2007 Jul; 23(7):1715-32. PubMed ID: 17588302
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Consensus on the clinical impact of the new scientific evidence available on benign prostatic hyperplasia].
    Cózar-Olmo JM; Hernández-Fenández C; Miñana-López B; Amón-Sesmero JH; Montlleó-González M; Rodríguez-Antolín A; Caballero-Martínez F
    Actas Urol Esp; 2012 May; 36(5):265-75. PubMed ID: 22475690
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate.
    Wasson JH; Reda DJ; Bruskewitz RC; Elinson J; Keller AM; Henderson WG
    N Engl J Med; 1995 Jan; 332(2):75-9. PubMed ID: 7527493
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Conservative Treatment for Benign Prostatic Hyperplasia in Patients With Bladder Stones.
    Yoshida T; Kinoshita H; Nakamoto T; Yanishi M; Sugi M; Murota T; Matsuda T
    Urology; 2015 Sep; 86(3):450-3. PubMed ID: 26235850
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Indications for coronary revascularisation: a Dutch perspective.
    Rigter H; Meijler AP; McDonnell J; Scholma JK; Bernstein SJ
    Heart; 1997 Mar; 77(3):211-8. PubMed ID: 9093036
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Understanding variability in physician ratings of the appropriateness of coronary angiography after acute myocardial infarction.
    Landrum MB; McNeil BJ; Silva L; Normand SL
    J Clin Epidemiol; 1999 Apr; 52(4):309-19. PubMed ID: 10235171
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Management of symptomatic BPH in the US: who is treated and how?
    Bruskewitz R
    Eur Urol; 1999; 36 Suppl 3():7-13. PubMed ID: 10559625
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of appropriateness criteria for colonoscopy: comparison between a standardized expert panel and an evidence-based medicine approach.
    Nicollier-Fahrni A; Vader JP; Froehlich F; Gonvers JJ; Burnand B
    Int J Qual Health Care; 2003 Feb; 15(1):15-22. PubMed ID: 12630797
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cost-effectiveness analysis of medical treatment of benign prostatic hyperplasia in the Brazilian public health system.
    Bahia LR; Araujo DV; Pepe C; Trindade M; Camargo CM; Javaroni V
    Int Braz J Urol; 2012; 38(5):595-605. PubMed ID: 23131517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.